Testing effectiveness (Phase 2)Study completedNCT00130637
What this trial is testing
Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
Who this might be right for
Anterior UveitisArthritis, Juvenile IdiopathicIritis+1 more
National Eye Institute (NEI) 6